HERZUMA

Google image searchProduct monograph

Active ingredient

trastuzumab, 150 MG/VIAL

DIN: 02506211

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: CELLTRION INC.

Date: 03-OCT-2024

ATC:

Reference brand drug: Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera

Pharmaceutical standard: BP

Search on Google